Holen Sie sich die Stockscreener-App
43.03
2.62%
1.10
Schlusskurs vom Vortag:
$41.93
Offen:
$41.91
24-Stunden-Volumen:
474.93K
Relative Volume:
0.78
Marktkapitalisierung:
$1.96B
Einnahmen:
$1.23B
Nettoeinkommen (Verlust:
$20.43M
KGV:
97.55
EPS:
0.4411
Netto-Cashflow:
$95.39M
1W Leistung:
+8.85%
1M Leistung:
+2.67%
6M Leistung:
-4.67%
1J Leistung:
+44.40%
1-Tages-Spanne:
$41.55
$43.13
1-Wochen-Bereich:
$38.53
$43.26
52-Wochen-Spanne:
$26.84
$55.00
Omnicell Inc Stock (OMCL) Company Profile
Firmenname
Omnicell Inc
Sektor
Branche
Telefon
(877) 415-9990
Adresse
4220 NORTH FREEWAY, FORT WORTH
Compare OMCL vs VEEV, BTSG, TEM, HQY, HNGE
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
OMCL
Omnicell Inc
|
43.03 | 1.89B | 1.23B | 20.43M | 95.39M | 0.4411 |
VEEV
Veeva Systems Inc
|
192.74 | 28.83B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
69.03 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
60.27 | 10.40B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
95.31 | 7.55B | 1.34B | 230.70M | 440.96M | 2.6695 |
HNGE
Hinge Health Inc
|
84.05 | 6.42B | 646.34M | -512.40M | 202.76M | -6.6871 |
Omnicell Inc Stock (OMCL) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-02-04 | Hochstufung | BofA Securities | Neutral → Buy |
| 2026-01-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-05-14 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-31 | Herabstufung | BofA Securities | Buy → Neutral |
| 2024-08-02 | Hochstufung | Barclays | Underweight → Equal Weight |
| 2024-01-03 | Eingeleitet | Barclays | Underweight |
| 2023-11-03 | Herabstufung | BTIG Research | Buy → Neutral |
| 2023-11-03 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2023-11-03 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-10-11 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-09-26 | Bestätigt | Wells Fargo | Underweight |
| 2023-08-02 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-07-20 | Herabstufung | Wells Fargo | Overweight → Underweight |
| 2023-02-27 | Hochstufung | The Benchmark Company | Hold → Buy |
| 2022-11-03 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2022-09-09 | Eingeleitet | BofA Securities | Buy |
| 2022-07-15 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2021-12-06 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-06-09 | Eingeleitet | JP Morgan | Neutral |
| 2021-05-24 | Eingeleitet | BTIG Research | Buy |
| 2021-02-02 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2020-12-08 | Eingeleitet | Berenberg | Buy |
| 2020-12-03 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2020-07-07 | Eingeleitet | Stephens | Overweight |
| 2020-02-07 | Bestätigt | Dougherty & Company | Buy |
| 2019-11-21 | Bestätigt | Dougherty & Company | Buy |
| 2019-07-26 | Hochstufung | Craig Hallum | Hold → Buy |
| 2019-03-07 | Bestätigt | Dougherty & Company | Buy |
| 2018-06-29 | Fortgesetzt | The Benchmark Company | Buy |
| 2017-09-05 | Bestätigt | The Benchmark Company | Buy |
| 2017-07-28 | Bestätigt | Dougherty & Company | Buy |
| 2017-04-21 | Herabstufung | Piper Jaffray | Overweight → Neutral |
| 2017-01-19 | Eingeleitet | Dougherty & Company | Buy |
| 2016-12-06 | Bestätigt | The Benchmark Company | Buy |
| 2016-07-07 | Bestätigt | FBR Capital | Outperform |
| 2016-03-21 | Bestätigt | Topeka Capital Markets | Buy |
| 2016-01-07 | Eingeleitet | The Benchmark Company | Buy |
| 2015-11-16 | Bestätigt | Topeka Capital Markets | Buy |
| 2015-10-30 | Bestätigt | FBR Capital | Outperform |
| 2015-09-28 | Hochstufung | Sidoti | Neutral → Buy |
| 2015-07-31 | Bestätigt | Topeka Capital Markets | Buy |
Alle ansehen
Omnicell Inc Aktie (OMCL) Neueste Nachrichten
Omnicell Appoints Nnamdi Njoku President, Retaining COO Role - Fort Worth Inc.
Omnicell, Inc. Announces Executive Changes - marketscreener.com
Omnicell Appoints Nnamdi Njoku as President, Stock Ticker OMCL - GuruFocus
Omnicell Promotes Nnamdi Njoku to President While Retaining COO Role - citybiz
Nnamdi Njoku appointed President of Omnicell (OMCL) while Randall Lipps remains CEO - Stock Titan
Omnicell appoints Nnamdi Njoku as president effective today By Investing.com - Investing.com Australia
Nnamdi Njoku Appointed President of Omnicell | Associated Press | syndication news - Enidnews.com
Nnamdi Njoku Appointed President of Omnicell – Company Announcement - Financial Times
Omnicell, Inc.(NasdaqGS: OMCL) added to Russell 2000 Value-Defensive Index - marketscreener.com
(OMCL) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Omnicell | 4: Statement of changes in beneficial ownership of securities-Officer Manley Corey J - Moomoo
Do options traders know something about Omnicell stock we don't? - MSN
Price to sales forward of Omnicell, Inc. – NASDAQ:OMCL - TradingView
Enterprise value to EBITDA forward of Omnicell, Inc. – NASDAQ:OMCL - TradingView
Price to earnings forward of Omnicell, Inc. – MUN:OC9 - TradingView
Price to sales forward of Omnicell, Inc. – MUN:OC9 - TradingView
Omnicell, Inc. Actuals & Estimates (NASDAQ:OMCL) - TradingView
OMCL Forecast — Price Target — Prediction for 2027 - TradingView
Price to book forward of Omnicell, Inc. – MUN:OC9 - TradingView
How Investors May Respond To Omnicell (OMCL) Options Volatility Surge Signaling Anticipated Stock Swing - simplywall.st
Do Options Traders Know Something About Omnicell Stock We Don't? - Yahoo Finance Australia
Omnicell Inc (OMCL) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Omnicell (OMCL) Stock Could Be 36.3% Undervalued After Specialty Pharmacy Leadership Hire - Sahm
Omnicell StockWeekly review and healthcare tech backdrop - AD HOC NEWS
Omnicell Inc (OMCL) Valuation: PE, PB & Fair Value Analysis - TradingKey
Omnicell Inc (OMCL) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Omnicell Inc (OMCL) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Omnicell Inc (OMCL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Liquidity Mapping Around (OMCL) Price Events - Stock Traders Daily
Omnicell Inc (OMCL) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Omnicell Inc (OMCL) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Omnicell Inc (OMCL) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Omnicell Inc (OMCL) Institutional Confidence - TradingKey
What Omnicell (OMCL)'s New Specialty Pharmacy Leader Means For Shareholders - simplywall.st
Analysts Offer Insights on Healthcare Companies: Omnicell (OMCL), Oric Pharmaceuticals (ORIC) and Pfizer (PFE) - The Globe and Mail
BofA Securities Maintains Omnicell(OMCL.US) With Buy Rating, Maintains Target Price $70 - Moomoo
Omnicell (NASDAQ:OMCL) Trading Down 4.9%Time to Sell? - MarketBeat
Omnicell (OMCL) is a top-ranked value stock: Should you buy? - MSN
Transcript : Omnicell, Inc. Presents at Goldman Sachs 47th Annual Global Healthcare Conference 2026, Jun-09-2026 03 - marketscreener.com
Omnicell: Why I’m Long Into Q2 Earnings Despite The Bookings Wobble (NASDAQ:OMCL) - Seeking Alpha
Earnings Preview: Omnicell to Report Financial Results Pre-market on April 28 - Moomoo
Omnicell appoints Dan Mandoli to lead specialty pharmacy unit - Investing.com UK
Omnicell, Inc. Announces Appointment of Dan Mandoli to Senior Vice President and General Manager, Specialty Pharmacy Services - marketscreener.com
Omnicell appoints Dan Mandoli to lead specialty pharmacy unit By Investing.com - Investing.com South Africa
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business - 巴士的報
Omnicell Selects Dan Mandoli to Lead Specialty Pharmacy Services Business – Company Announcement - Financial Times
Intech Investment Management LLC Sells 30,447 Shares of Omnicell, Inc. $OMCL - MarketBeat
Omnicell (OMCL) may find a bottom soon, here's why you should buy the stock now - MSN
Omnicell Shareholders Back Governance Amendment And Long Term Growth Focus - Yahoo Finance
Should Omnicell’s (OMCL) Governance Moves and Conference Spotlight Recast Its Recurring Revenue Narrative? - Sahm
OMCL Technical Analysis & Stock Price Forecast - Intellectia AI
Finanzdaten der Omnicell Inc-Aktie (OMCL)
Umsatz
Nettogewinn
Free Cashflow
ENV
Omnicell Inc-Aktie (OMCL) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Manley Corey J | EVP&CHIEF LEGAL/ADMIN OFFICER |
May 18 '26 |
Sale |
43.22 |
5,025 |
217,180 |
112,783 |
1.79%
0.10%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):